(Q53215753)

12 May 2018

title

Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease. (English)

1 reference

12 May 2018

author

Johannes Kornhuber

4

1 reference

12 May 2018

author name string

Thome J

1

1 reference

12 May 2018

Gsell W

2

1 reference

12 May 2018

Rösler M

3

1 reference

12 May 2018

Frölich L

5

1 reference

12 May 2018

Hashimoto E

6

1 reference

12 May 2018

Zielke B

7

1 reference

12 May 2018

Wiesbeck GA

8

1 reference

12 May 2018

Riederer P

9

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

12 May 2018

published in

Life Sciences

1 reference

12 May 2018

volume

60

1 reference

12 May 2018

page(s)

13-19

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Alzheimer's disease. A glycation connection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Abnormalities of Glucose Metabolism in Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

[Neuropathologic, immunologic and psychobiological aspects of Alzheimer's dementia]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Demential syndromes and the lipid metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Involvement of free radicals in dementia of the Alzheimer type: a hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Oxidative stress: free radical production in neural degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Oxygen radicals and neuropsychiatric illness. Some speculations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Bioenergetic and oxidative stress in neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Free radicals in brain metabolism and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Prooxidant activity of transferrin and lactoferrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Pathological verification of ischemic score in differentiation of dementias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Effects of oxidative stress on expression of extracellular superoxide dismutase, CuZn-superoxide dismutase and Mn-superoxide dismutase in human dermal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Decrease in Cu/Zn- and Mn-superoxide dismutase activities in brain and spinal cord of patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

An enzyme-linked immunosorbent assay for plasma-lactoferrin. Concentrations in 362 healthy, adult blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Plasma and serum lactoferrin levels in cystic fibrosis. Relationship with the presence of cystic fibrosis protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2896%2900583-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(96)00583-8

1 reference

12 May 2018

PubMed ID

8995527

1 reference

12 May 2018